Ligand Pharmaceuticals Inc. (LGND) Presents New Preclinical Data on its Lead SARM Molecule LGD-4033 at the Gerontological Society of America Annual Meeting
11/20/2009
More...
|
Inovio Biomedical Corporation (INO) Universal Flu Vaccines Demonstrate Broadly Protective Immune Responses Against Multiple Seasonal & Pandemic Influenza Viruses in Pre-Clinical Studies
11/20/2009
More...
|
Inovio Biomedical Corporation (INO) Universal DNA Vaccine for Chikungunya Virus Demonstrates Protective Antibody Responses in Monkey Model
11/19/2009
More...
|
Peregrine Pharmaceuticals, Inc. (PPHM) Presents Promising Antiviral Data at 2009 Chemical and Biological Defense Science & Technology Conference
11/18/2009
More...
|
Synta Pharmaceuticals Presents Preclinical Data on Next Generation Hsp90 Inhibitor, STA-9090
11/18/2009
More...
|
Alnylam Pharmaceuticals (ALNY) Presents New Pre-clinical Data on ALN-VSP, an RNAi Therapeutic for the Treatment of Liver Cancer
11/18/2009
More...
|
Cardioxyl Pharmaceuticals Announces Pre-Clinical Results on Lead Clinical Candidate, CXL-1020 at American Heart Association Scientific Sessions 2009
11/18/2009
More...
|
PanGenex Corporation Expands Clinical Trial Sites after Promising Pre-Clinical Data about Lower Coronary Arterial Calcium Scores in Cardiac Patients
11/18/2009
More...
|
YM BioSciences (YM.TO) ANNOUNCES NIMOTUZUMAB Results
11/18/2009
More...
|
GliaMed to Present Pre-Clinical Data Demonstrating the Regeneration of Tissue through the In vivo Induction and Recruitment of Stem Cells
11/17/2009
More...
|
Calistoga Pharmaceuticals Presents Preclinical Data on CAL-120 at The AACR-EORTC-NCI Molecular Targets & Cancer Therapeutics Conference
11/17/2009
More...
|
ReNeuron Presents Positive Pre-Clinical Efficacy Data With Ren009 Stem Cell Therapy For Peripheral Arterial Disease At Leading US Scientific Conference
11/16/2009
More...
|
Senesco Technologies, Inc. (SNT) Presents Pre-Clinical Stability and Biological Activity Data on SNS-01 at the 2009 AACR-NCI-EORTC Molecular Targets and Cancer Therapeutics Conference
11/12/2009
More...
|
Champions Biotechnology, Inc. (CSBR) to Present Data at AACR-EORTC 2009 Regarding the Predictability of Biomerk Tumorgraft(TM) Platform to Guide Personalized Cancer Treatment and Accelerate Oncology Drug Development
11/12/2009
More...
|
Champions Biotechnology, Inc. (CSBR) to Present Data at AACR-EORTC 2009 Regarding the Predictability of Biomerk Tumorgraft(TM) Platform to Guide Personalized Cancer Treatment and Accelerate Oncology Drug Development
11/12/2009
More...
|
Stem Cells: Cincinnati Children's Hospital Medical Center Scientists Successfully Reprogram Blood Cells
11/12/2009
More...
|
Geron Corporation (GERN) Collaborators Publish Data on hESC-Derived Glial Progenitor Cell Therapy in Cervical Spinal Cord Injury
11/11/2009
More...
|
Amsterdam Molecular Therapeutics (AMT) Successful in Preclinical Treatment of DMD
11/11/2009
More...
|
DARA BioSciences, Inc. Presented Promising Preclinical Type 2 Diabetes Study Results at the Cambridge Healthtech Institute's Conference, "Targeting Diabetes with Novel Therapeutics"
11/10/2009
More...
|
ImmuneRegen BioSciences, Inc. (IRBO) Reports Positive Results of Homspera(R) in Treating Highly Pathogenic Influenza
11/10/2009
More...
|
BrainStorm Cell Therapeutics Inc. Therapy Treatment Shown To Be More Effective Than Other Current Potential Stem Cell Treatments in Tel Aviv University Study
11/9/2009
More...
|
NexBio, Inc. Presents Data Showing Anti-Asthma Activity of DAS181 (Fludase(R)*) at ACAAI 2009
11/9/2009
More...
|
Puredel Limited Release: Ossulin(TM) Oral Insulin Data to be Presented at The San Francisco Diabetes Congress on November 6, 2009
11/6/2009
More...
|
Data Demonstrating Aeolus Pharmaceuticals Inc. (AOLS.OB)' AEOL 10150's Efficacy as a Broad Spectrum Pharmaceuticals, Inc. (SPPI) Countermeasure Against Radiological and Chemical Threats Presented at the GHSI Public Health Emergency Medical Countermeasures Workshop
11/5/2009
More...
|
Cellumen, Inc. Finds Increased Predictivity for Human DILI Through Rat Hepatocyte Panel
11/5/2009
More...
|
Alnylam Pharmaceuticals (ALNY) Presents New Pre-Clinical Data on RNAi Therapeutics at Oligonucleotides Therapeutics Society (OTS) Meeting
11/5/2009
More...
|
Promedior Announces Publication of Preclinical Studies in Science Translational Medicine Demonstrating that hSAP Inhibits Kidney Fibrosis
11/4/2009
More...
|
Aeolus Pharmaceuticals Inc. (AOLS.OB)' AEOL 10150 Protects Lungs Against Chlorine Gas Exposure in Animal Studies
11/4/2009
More...
|
SCYNEXIS, Inc.' SCY-635 Demonstrates Positive Antiviral Activity in Combination with Approved and Investigational Anti-HCV Agents
11/3/2009
More...
|
Idera Pharmaceuticals, Inc. (IDRA) Presents Preclinical Data on IMO-2125, its Lead Drug Candidate for Chronic Hepatitis C Virus Infection, at Liver Meeting 2009
11/3/2009
More...
|
Developmental Drug May Help Bone Fractures Heal After Radiation Exposure, University of Pittsburgh School of Medicine Study
11/3/2009
More...
|
Geron Corporation (GERN) (JOBS), FDA Agree on Spinal Injury Drug Trial
11/2/2009
More...
|
Alternatively Spliced Tissue Factor Identified As Promising New Biomarker For Aggressive Cancers, University of Cincinnati and Leiden University Medical Center Study
11/2/2009
More...
|
Alnylam Pharmaceuticals (ALNY) Presents New Pre-Clinical Data on ALN-TTR, an RNAi Therapeutic for the Treatment of Transthyretin-Mediated Amyloidosis
11/2/2009
More...
|
Avila Therapeutics Presents Data on Its Novel, Orally-Available Protease Inhibitor, AVL-181, Demonstrating Viral Clearance of Hepatitis C Virus in Preclinical Models
11/2/2009
More...
|
Third Compound from Albany Molecular Research, Inc. (AMRI), Bristol-Myers Squibb Company (BMY) Collaboration Selected for Preclinical Development
11/2/2009
More...
|
NovaBay Pharmaceuticals, Inc. (formerly known as NovaCal Pharmaceuticals, Inc.)'s Aganocides Show Penetration and Efficacy in a Pre-Clinical Infected Human Nail Model of Onychomycosis
10/30/2009
More...
|
Geron Corporation (GERN) and FDA Reach Agreement on Clinical Hold
10/30/2009
More...
|
Drug-radiation Combo Eradicates Lung Cancer In Mice, UT Southwestern Medical Center Study
10/30/2009
More...
|
SCYNEXIS, Inc. to Present HCV Data on Novel Cyclophilin Inhibitor SCY-635 at AASLD Annual Meeting
10/28/2009
More...
|
US FDA Panel Says More Study on Human Genome Sciences, Inc. (HGSI) (JOBS) Anthrax Drug
10/28/2009
More...
|
Aquatrove Presents Positive Data on Conceive Plus(TM) at65th Annual Meeting of the American Society for Reproductive Medicine
10/27/2009
More...
|
PharmaGap Inc. (GAP) Reports That GAP-107B8 Showed Strong and Consistent Anti-Cancer Activity in a Wide Range of Cancers in NCI Test
10/27/2009
More...
|
Nervous System Drug-by-design: Formulation May Slow Parkinson's, Alzheimer's, Huntington's, Tel Aviv University Study
10/27/2009
More...
|
Cocaine Exposure During Pregnancy Leads To Impulsivity In Male, Not Female, Monkeys, Wake Forest University School of Medicine Study
10/26/2009
More...
|
Vical Incorporated (VICL)'s Vaxfectin(R) Adjuvant Drives 200-Fold Increase in Antibody Responses With Sanofi Pasteur (SASY.PA) Fluzone(R) Seasonal Influenza Vaccine
10/26/2009
More...
|
Myriad Pharmaceuticals, Inc.' Azixa(TM) is Efficacious in a Model of Human Brain Cancer and Its Activity is Additive With Avastin(R)
10/26/2009
More...
|
Halsa Pharmaceuticals Announces ZAG Demonstrates Weight Loss, Rise in Temperature and Reduction of Diabetes Symptoms in Preclinical Studies at Obesity 2009 Annual Scientific Meeting
10/26/2009
More...
|
Inhibitex, Inc. (INHX) Announces Data Presentation at the 60th Annual Meeting of the American Association for Study of Liver Diseases
10/26/2009
More...
|
Human Genome Sciences, Inc. (HGSI) Anthrax Drug Said to Work in Animals
10/23/2009
More...
|
New Animal Study Featured in the Journal of Cellular Biochemistry Supports Rexahn Pharmaceuticals, Inc.' Archexin(TM) as Potent Inhibitor of Human Cancer Cell Growth
10/22/2009
More...
|
Pharming Group (PHGUF.PK) Recombinant Human C1 Inhibitor: Results In Pre-Clinical Ischaemic Reperfusion Model Confirm Potential For New Indications
10/22/2009
More...
|
KAI Pharmaceuticals, Inc. Reports Positive Preclinical Results in Pain Therapeutic Program Targeting Gamma Protein Kinase C (PKC) Pathway
10/20/2009
More...
|
XOMA (US) LLC (XOMA) Presents First XOMA 052 Cardiovascular Disease Animal Model Results
10/20/2009
More...
|
Sernova Corp. (SVA.TO)'s Cell Pouch System(TM) and Sertolin(TM) Preclinical Efficacy Presented at Leading International Islet Transplant Conference
10/20/2009
More...
|
Idera Pharmaceuticals, Inc. (IDRA) Presents Preclinical Data at ACR/ARHP 2009 Annual Meeting on IMO-3100, a Toll-Like Receptor Antagonist, in Combination with Enbrel(R) in Arthritis Model
10/19/2009
More...
|
Proteolix, Inc. to Present Preclinical Data on Carfilzomib and PR-957 at the 2009 ACR/ARHP Annual Meeting
10/19/2009
More...
|
CEL-SCI (CVM) Presents Data at American College of Rheumatology Conference
10/19/2009
More...
|
Phytopharm PLC (PYM.L) Shares Soar on Parkinson's Drug Promise; Stock Up 339.64% at Market Close
10/16/2009
More...
|
Hemispherx Biopharma (HEB) Release: Japanese National Institutes of Health (NIH) Research Reaffirms and Expands Pandemic Flu Protection by Ampligen(R)
10/15/2009
More...
|
Animal Data Demonstrating Aeolus Pharmaceuticals Inc. (AOLS.OB)'s AEOL 10150's Efficacy in Mitigating Radiation Damage to the Lung Presented at the 55th Annual Meeting of the Radiation Research Society
10/15/2009
More...
|
Dogs Aid In Advancing Human Cancer Therapy, National Cancer Institute Scientists Say
10/14/2009
More...
|
Capstone Therapeutics (CAPS) Announces Presentation of Chrysalin(R) (TP508) Pre-Clinical Data At the American College of Surgeons 95th Annual Clinical Conference Demonstrating Significant Benefit in a Model of Acute Heart Disease and Elevated Cholesterol
10/14/2009
More...
|
Nymox Pharmaceutical (NYMX)'s NX-1207 to be Clinically Tested for Prostate Cancer
10/14/2009
More...
|
Cellceutix Poster Presented At American Association for Cancer Research; Dr. Menon Selected for Expert Panel
10/13/2009
More...
|
Antisense Therapeutics Limited (ANP.AX) Announces ATL1103 on Track to Move Into Clinical Development
10/13/2009
More...
|
NasVax Announces Positive Results from Preclinical Testing of Swine Flu Vaccine using its Novel Adjuvant
10/13/2009
More...
|
Pieris Reports Preclinical Development Progress of its Next Generation VEGF Antagonist PRS-050 Program on Track to Commence Clinical Trials as Planned
10/9/2009
More...
|
RXi Pharmaceuticals (RXII) Presented New Pre-Clinical Animal Data at its Annual Investor Day
10/8/2009
More...
|
Hybrigenics' Inecalcitol Shows Promising Preclinical Results Against Hormone-Dependent Prostate Cancer
10/8/2009
More...
|
Aeolus Pharmaceuticals Inc. (AOLS.OB)'s AEOL 10150 Protects Lungs Against Mustard Gas Exposure in Animal Studies
10/7/2009
More...
|
Cellceutix Compound Shows Significant Effect On Psoriasis
10/6/2009
More...
|
PDS Biotechnology Corporation Demonstrates Pre-Clinical Safety of its Versamune(TM)-Based HPV Product
10/6/2009
More...
|
Neovacs SA: Encouraging VEGF Kinoid Results In AMD Model Presented At The European Association For Vision And Eye Research (EVER) Conference
10/6/2009
More...
|
Inovio Biomedical Corporation Demonstrates Protective Immune Responses Against Novel H1N1 (2009) Influenza Virus in Ferret Model
10/5/2009
More...
|
Avila Therapeutics Presents Preclinical Data on its Novel, Orally-Available, Pan-Genotype Protease Inhibitor, AVL-181, Demonstrating Protein Silencing of Hepatitis C Virus
10/5/2009
More...
|
WellGen, Inc. Achieves Important Milestone in Development of Medical Food for Diabetes
10/1/2009
More...
|
Incept BioSystems Initiates First Human Clinical Trial of its SMART Embryo Culture System for In Vitro Fertilization (IVF)
9/30/2009
More...
|
InteKrin Therapeutics Presents Positive Long Term INT131 Preclinical Cardiovascular Safety Data at the 45th Annual European Association for the Study of Diabetes Meeting
9/30/2009
More...
|
Advanced Life Sciences Holdings, Inc. (ADLS)'s Restanza Demonstrates Efficacy in Plague Pivotal Animal Study
9/29/2009
More...
|
RegeneRx Biopharmaceuticals, Inc. (RGRX)'s Tß4 Significantly Improves Functional Recovery in Multiple Sclerosis Animal Model
9/29/2009
More...
|
Vical Incorporated (VICL) Presents Positive Preclinical Results with Vaxfectin(R)-Formulated, Peptide-based Cancer Vaccine
9/24/2009
More...
|
Versartis, Inc. Presents Preclinical Data for Novel Type 2 Diabetes Drug
9/23/2009
More...
|
Advanced Cell Technology Completing Pre-Clinical Activities in Preparation for IND Filing
9/22/2009
More...
|
Protalix Biotherapeutics Reports Preclinical Data on Anti-TNF Follow-on Biologic Arthritis Drug
9/22/2009
More...
|
Paralyzed Rats Walk Again, University of California, Los Angeles (UCLA) Scientist Use Drug-Electricity Combo to Make Paralyzed Rats Sprint
9/21/2009
More...
|
Chocolate Treats Migraines, Mississippi State University Study
9/18/2009
More...
|
LEAD Therapeutics, Inc. Presents New Antibiotic With Potent Activity Against Drug Resistant Bacteria at the 49th ICAAC
9/15/2009
More...
|
Mesoblast Limited Disc Repair Results Highlighted At Key Orthopaedic Conference
9/15/2009
More...
|
ChemDiv, Inc. and iDialog Nominate Novel Inhibitor of Hepatitis C for Clinical Development
9/15/2009
More...
|
Alnylam Pharmaceuticals (ALNY) and Medtronic, Inc. (MDT) Present New Late-Stage Pre-clinical Data on ALN-HTT, an RNAi Therapeutic for the Treatment of Huntington's Disease
9/15/2009
More...
|
Mayo Clinic: Researchers Identify Two Genes as Potential Therapeutic Targets for Multiple Sclerosis
9/14/2009
More...
|
Cytori Therapeutics, Inc. (CYTX) Reports Preclinical Results that Suggest Adipose-Derived Regenerative Cells may Reverse Periodontal Disease
9/14/2009
More...
|
Aeolus Pharmaceuticals Inc. (AOLS.OB) Initiates Second Study of AEOL 10150 as a Countermeasure to Radiation Exposure in Mice
9/14/2009
More...
|
AVI BioPharma, Inc. (AVII) Demonstrates Effectiveness of Immune Control via RNA-Based Therapeutics in Hemorrhagic Virus Infections
9/14/2009
More...
|
MethylGene Presents Preclinical Data for Its Beta-Lactamase Inhibitor, MG96077, at the 49th Annual ICAAC Meeting
9/14/2009
More...
|
NanoBio Corporation Presents Key Data on the Use of Nanoemulsions to Treat Burn Wound Infections
9/14/2009
More...
|
Ascent Therapeutics Achieves Preclinical in vivo Proof-of-Principle with Novel Pepducin(TM) GPCR Modulator Platform and Strengthens Senior Management Team
9/11/2009
More...
|
Newron Pharmaceuticals Release: Ralfinamide Uniquely Shows Analgesic Effects In A Central Pain Model
9/11/2009
More...
|
Mesoblast Limited Proprietary Stem Cells Successfully Repair/Regenerate Damaged Intervertebral Disc Cartilage
9/10/2009
More...
|
Vical Incorporated (VICL) (JOBS) Says H1N1 Vaccine Showed Promise in Animals
9/10/2009
More...
|
Biovista Announces Positive Efficacy Results in a Pre-clinical Trial of its BVA-201 Repositioned Drug for Multiple Sclerosis
9/9/2009
More...
|
Moths As Good As Mice For Many Drug Tests, National University Of Ireland Study
9/8/2009
More...
|
Sangamo BioSciences, Inc. (SGMO)'s Zinc Finger Nuclease Technology Used to Efficiently Modify Human Stem Cells
9/8/2009
More...
|
Aeolus Pharmaceuticals Inc. (AOLS.OB) Initiates Study of AEOL 10150 as a Countermeasure to Radiation Exposure in Non-Human Primates
9/8/2009
More...
|
Enabling Capabilities of Inovio Biomedical Corporation's Electroporation Delivery Technology with SIV DNA Vaccine Confirmed in Collaborative Study With National Cancer Institute
9/3/2009
More...
|
StemCells Inc. (STEM) Demonstrates Protection of Neurological Function in Batten Mouse
9/3/2009
More...
|
Newron Pharmaceuticals: Preclinical Results Of Ralfinamide In A Model Of Central Pain To Be Presented At The European Federation Of IASP Chapters (EFIC) 6th International Congress
9/3/2009
More...
|
Zealand Pharma Advances A New Generation Of Type 2 Diabetes Treatment
9/1/2009
More...
|
Advanced Life Sciences Holdings, Inc. (ADLS)'s Restanza Demonstrates Efficacy in Treating Anthrax Infection
8/31/2009
More...
|
New Braasch Biotech Vaccine Technology Provides Growth Hormone and IGF-1 Treatments Without the Use of Drugs
8/31/2009
More...
|
Nymox Pharmaceutical (NYMX) Says Drug Shrinks Rodent Tumors
8/28/2009
More...
|
EU Chemicals Law "Spells Surge In Animal Testing", Bloomberg School of Public Health Study
8/27/2009
More...
|
Geron Corporation (GERN) (JOBS) Comments on FDA Hold on Spinal Cord Injury Trial
8/27/2009
More...
|
Nymox Pharmaceutical (NYMX)'s NX-1207 Shows Major Effect On Liver Cancer
8/26/2009
More...
|
NovaBay Pharmaceuticals, Inc. (formerly known as NovaCal Pharmaceuticals, Inc.) to Present New Pre-Clinical Data on Lead Anti-Infective Compound for use in Onychomycosis at the 2009 IDSA Annual Meeting
8/24/2009
More...
|
Patrys Limited Completes Preclinical Safety Analysis for Lead Products PAT-SM6 and PAT-LM1
8/24/2009
More...
|
PCI Biotech: Anti-Tumour Drug More Potent With Light-Directed Delivery
8/19/2009
More...
|
Animal Tests Validate Novavax, Inc. (NVAX) Flu Vaccine, Company Says
8/18/2009
More...
|
Adamas Pharmaceuticals Signs CRADA With U.S. Navy to Conduct Preclinical Studies of Triple Combination Antiviral Drug Therapy for Influenza A, Including the Novel H1N1 Pandemic Strain
8/18/2009
More...
|
Critical Outcome Technologies Inc. Release: Oral COTI-2 Plus Doxil(R) Is Superior to Doxil Alone in an Animal Model of Human Ovarian Cancer
8/18/2009
More...
|
AlphaRx Inc. (ALRX) Completes Lyophilization Process for Zysolin(TM)
8/17/2009
More...
|
NanoBio Corporation to Present Preclinical Data on its Novel, Nanoemulsion-based Vaccine Adjuvant Platform at the Immunotherapeutics & Vaccine Summit
8/17/2009
More...
|
CytRx Corporation (CYTR)'s Drug Candidate INNO-206 Produces Statistically Significant Tumor Shrinkage in Animal Model of Small Cell Lung Cancer
8/12/2009
More...
|
Multiple Sclerosis Successfully Reversed In Mice: New Immune-suppressing Treatment Forces The Disease Into Remission, Jewish General Hospital Lady Davis Institute for Medical Research And McGill University Study
8/12/2009
More...
|
ReNeuron Announces Publication Of Pre-Clinical Data With Its Ren003 Programme For Diseases Of The Retina
8/10/2009
More...
|
Transposagen Biopharmaceuticals, Inc. Creates a Rat Model of the Human Immune System SCID Rat Seen as Superior Cancer and Transplantation Model
8/6/2009
More...
|
Generex Biotechnology Corporation (GNBT) Announces Publication of Pre-Clinical Studies Demonstrating Utility of Its Vaccine Platform for Addressing Pandemic Influenza
8/5/2009
More...
|
RXi Pharmaceuticals Presented Data from Animal Trials Demonstrating the Utility of Self-Delivering RNAi at IBC’s Oligonucleotide Therapeutics Conference
8/5/2009
More...
|
MDRNA, Inc. Reports Positive In Vivo Data Demonstrating That Its UsiRNAs Are Highly Potent Against Metabolic and Oncology Targets
8/3/2009
More...
|
FDA Lifts Partial Clinical Hold on Epilepsy Drug Says Icagen
8/3/2009
More...
|
AVEO Pharmaceuticals, Inc.'s Tivozanib Demonstrates Anti-Tumor Activity in Engineered Lung Tumors Exhibiting Treatment Resistant Mutations
7/31/2009
More...
|
Scientists Slowed Growth Of Ovarian Tumors In Mice Using Nanoparticles To Deliver Suicide Genes, Lankenau Institute for Medical Research And Massachusetts Institute of Technology (MIT) Study
7/30/2009
More...
|
Adamis' Patented Vaccine Technology Induces Broad Immunity Against Influenza Virus
7/30/2009
More...
|
NanoBio Corporation to Announce Key Preclinical Data on Nanoemulsions for the Treatment of Acne at American Academy of Dermatology Summer Meeting
7/29/2009
More...
|
Inovio Biomedical Corporation Universal Influenza Vaccines Demonstrate 100% Protection Against Current Pandemic A/H1N1 Influenza Viruses in Animal Studies
7/29/2009
More...
|
Foresight Biotherapeutics Announces Initiation of Viral Conjunctivitis Clinical Trial
7/28/2009
More...
|
CytRx Corporation (CYTR) Drug Candidate INNO-206 Results in Ovarian Tumor Shrinkage in Animal Trials
7/28/2009
More...
|
Quark Pharmaceuticals Inc. (QURK) Announces Data Indicating Potential Utility of QPI-1007 for Treatment of Glaucoma
7/27/2009
More...
|
AlphaRx Inc. (ALRX) Presents Positive Preclinical Data on Zysolin(TM) Inhalable Nanoparticles at Controlled Release Society Annual Meeting
7/23/2009
More...
|
Cellceutix's Cancer Drug Shows No Significant Indications of Toxicity
7/22/2009
More...
|
Novavax, Inc. (NVAX) Announces Selection of a Respiratory Syncytial Virus Vaccine Candidate for Advanced Preclinical Studies
7/22/2009
More...
|
Compugen Ltd. (CGEN) Announces Positive Therapeutic Effects of Novel Peptide in Animal Model of Retinopathy
7/21/2009
More...
|
Cell Therapeutics, Inc. (CTIC) Release: National Cancer Institute Research Identifies Unique Mechanism of Brostallicin's Anti-Tumor Effectiveness
7/21/2009
More...
|
AlphaVax, Inc. Announces Results from Initial Testing of Its H1N1 (Swine) Influenza Vaccine
7/20/2009
More...
|
Cardax Pharmaceuticals Inc. Nominates Clinical Candidate Heptax for Liver Disease; Heptax Ameliorates Inflammation and Oxidative Stress Related to Liver Disease and Metabolic Syndrome
7/20/2009
More...
|
CytRx Corporation (CYTR)'s INNO-206 Significantly Inhibits Pancreatic Cancer Growth in Animal Trials
7/20/2009
More...
|
Axentis Pharma AG's Cystic Fibrosis Liposomal Tobramycin Receives Second Orphan Drug Designation Within Weeks
7/16/2009
More...
|
Biolex Therapeutics Announces Oral Presentation of Preclinical Results for Direct-Acting Thrombolytic BLX-155 at ISTH Meeting
7/16/2009
More...
|
Marcadia Biotech: Novel Pharmaceutical Treatment for Obesity Demonstrates Unprecedented Efficacy in Animal Models
7/15/2009
More...
|
Inspiration Biopharmaceuticals Presents Safety Data on IB1001, a Novel Recombinant Factor IX for the Treatment of Hemophilia
7/15/2009
More...
|
Roche (RHHBY) Drug Blocks Common Cancer Pathway In Mice
7/15/2009
More...
|
EnVivo Pharmaceuticals, Inc. Announces Reversal of Cognitive Deficits in Alzheimer's Disease Transgenic Mouse Model With Gamma-Secretase Modulator
7/15/2009
More...
|
DARA BioSciences, Inc. Releases Promising Preclinical Type 2 Diabetes Data for First-in-Class DB959
7/14/2009
More...
|
Inovio Biomedical Corporation H1N1 Influenza DNA Vaccines Demonstrate 100% Responses Against Swine Flu in Vaccinated Pigs
7/13/2009
More...
|
Cellceutix Announces Kevetrin(tm) Animal Model Testing Success Against Multi-Drug Resistant Lung Cancer Cell Lines
7/13/2009
More...
|
Veridex, LLC: Monitoring Circulating Tumor Cells With the CellSearch(R) System Can Predict Prognosis in Metastatic Breast Cancer
7/13/2009
More...
|
Foresight Biotherapeutics Announces FST-100 Displays Robust Clinical Improvement in Adenoviral Conjunctivitis Model
7/9/2009
More...
|
Anthrax Drug Could Thwart Terrorists, Human Genome Sciences, Inc. (HGSI)'s Researchers Say
7/9/2009
More...
|
Nanobiotix Reports Final Preclinical Safety Data: Its 'NBTXR3' Nanoparticles Are Designed to Be Safe and Effective Treatment for Radiosensitive and Radioresistant Tumors
7/9/2009
More...
|
AlphaRx Inc. (ALRX) Reports Positive Preclinical Data on GAI-122 Against Liver Disease
7/8/2009
More...
|
Foresight Biotherapeutics Announces FST-100 Displays Robust Clinical Improvement in Adenoviral Conjunctivitis Model
7/8/2009
More...
|
AEterna Zentaris (AEZS): New Data Published on its Ghrelin Antagonist Compound, AEZS-123 (JMV2959), Supports its Use in Alcohol Addiction
7/7/2009
More...
|
Access Pharmaceuticals (ACCP): Thiarabine Demonstrates a Reduction of Both Inflammatory and Erosive Disease Parameters in Rheumatoid Arthritis
7/7/2009
More...
|
Pharmasset, Inc. (VRUS) Nominates PSI-938 as a New Nucleotide Analog Inhibitor of Hepatitis C for Preclinical Development
7/7/2009
More...
|
Aeolus Pharmaceuticals Inc. (AOLS.OB)'s AEOL 10150 Significantly Increases Survival in Mice Exposed to Radiation when Administered After Exposure
7/6/2009
More...
|
Critical Outcome Technologies Inc.: Intravenous COTI-2 in Combination with Doxil(R) (Doxorubicin HCl) is More Effective Than Treatment with Doxil Alone in an Animal Model of Human Ovarian Cancer
7/6/2009
More...
|
Vical Incorporated (VICL) H1 Influenza Vaccine Delivers Robust Preclinical Results With 100% Response
6/30/2009
More...
|
AlphaRx Inc. (ALRX) and Gaia BioPharma Report Positive Efficacy Results in a Pre-Clinical Trial of GAI-122 Injectable Nano-emulsion for Post-operative Delirium
6/29/2009
More...
|
Ablynx Announces A Novel Preclinical Development Candidate Targeting Il6r
6/29/2009
More...
|
Palkion Selects Novel Oral Development Candidate for the Treatment of Anemia
6/29/2009
More...
|
Creato Flu GmbH: Innovative Broad Spectrum Oral Influenza Vaccine
6/26/2009
More...
|
CytRx Corporation (CYTR) to Present Statistically Significant Evidence of Arimoclomol’s Ability to Protect Experimental Animals from the Effects of Hypoxia at the 2009 International Society on Oxygen Transport to Tissue Conference
6/25/2009
More...
|
Preclinical Proof-of-Concept Studies Published for Novavax, Inc. (NVAX) Seasonal Influenza Virus-Like-Particle Vaccine
6/24/2009
More...
|
Biovista Announces Positive Efficacy Results in a Pre-Clinical Trial of its BVA-601 Repositioned Drug for Epilepsy
6/23/2009
More...
|
Compugen Ltd. (CGEN) Announces Positive Therapeutic Effects of Novel Peptide in Animal Model of Inflammatory Bowel Disease
6/23/2009
More...
|
Cortex Pharmaceuticals, Inc. (COR) Release: Novel Compounds May Help Protect Against Respiratory Depression
6/23/2009
More...
|
Avir Green Hills Biotechnology Trade AG: Excellent Preclinical Data on Novel Type of Intranasal H5N1 Influenza Vaccine – Technology Also Suitable for Vaccination against Swine Flu
6/19/2009
More...
|
AlphaRx Inc. (ALRX): Zysolin(TM) Pre-clinical Data Supports Once-a-day Dosing in Humans
6/18/2009
More...
|
Alnylam Pharmaceuticals (ALNY) and Collaborators Present New Pre-Clinical Research Findings on RNAi Therapeutics Targeting PCSK9, a Genetically Validated Regulator of LDL Metabolism
6/18/2009
More...
|
Neurocrine Biosciences, Inc. (NBIX) Presents Elagolix Data
6/18/2009
More...
|
CytRx Corporation (CYTR)'s Tamibarotene Demonstrates Statistically Significant Anti-Tumor Activity in Animal Trial for Multiple Myeloma
6/17/2009
More...
|
VaxInnate Corporation Reports Positive Results from Preclinical Testing of Swine Flu Vaccine Developed Using Novel Technology
6/17/2009
More...
|
Immunomedics, Inc. (IMMU) Reports New Antibody for Pretargeted Imaging and Therapy of Colorectal Cancer
6/16/2009
More...
|
AlphaRx Inc. (ALRX) and Gaia BioPharma Provide GAI-122 Development Update
6/16/2009
More...
|
Proteolix, Inc. Drug Candidate, PR-957, Prevents Disease Progression in Rheumatoid Arthritis Models by Selective Inhibition of the Immunoproteasome
6/15/2009
More...
|
Idera Pharmaceuticals, Inc. (IDRA) Announces Presentations of Preclinical Data on Modulation of Toll-like Receptors 3, 7, and 9 through Antisense
6/15/2009
More...
|
Amira Pharmaceuticals, Inc. to Present Preclinical Data from LPA1 Receptor Antagonist Program at FASEB Summer Research Conference
6/15/2009
More...
|
New Animal Study of Rexahn Pharmaceuticals, Inc.'s Serdaxin(TM) Shows Drug's Promise to Treat Anxiety and Depression with Minimal Side Effects
6/15/2009
More...
|
Mirna Therapeutics, Inc. Presents Data at Keystone Symposium on MicroRNA and Cancer
6/15/2009
More...
|
Patrys Limited Announces Positive Results from Preclinical Safety Studies for Lead Products PAT-LM1 and PAT-SM6
6/15/2009
More...
|
Chelsea Therapeutics, Inc. to Present Data Demonstrating Efficacy of CH-4051 in Rat Collagen-Induced Arthritis Model at EULAR 2009
6/11/2009
More...
|
Versartis, Inc. Presents Positive Preclinical Data on Two Product Candidates at ENDO 09
6/10/2009
More...
|
Acceleron Pharma to Present ACE-031 Preclinical Study Results as Treatment for Loss of Muscle Mass and Function
6/10/2009
More...
|
Curis, Inc. (CRIS) Publishes Preclinical Data for Heat Shock Protein 90 Molecule CUDC-305 in Clinical Cancer Research
6/10/2009
More...
|
Arete Therapeutics Presents Positive Clinical and Preclinical Data for AR9281
6/9/2009
More...
|
XOMA (US) LLC (XOMA) Presents Data At American Diabetes Association Demonstrating Improvement in Diabetes and Inflammatory Measures in Animal Model With XOMA 052
6/9/2009
More...
|
GeneSegues, Inc. and Collaborators at University of Minnesota Publish New Research Showing Targeted Nanocapsule Delivery of Plasmid DNA for Long Term Treatment of Hemophilia in Mice
6/9/2009
More...
|
Celator Pharmaceuticals, Inc. Presents Data on the Activity of CPX-351 Against Leukemia at the European Hematology Association Congress
6/8/2009
More...
|
Progenics Pharmaceuticals, Inc. (PGNX) Provides Update on Hepatitis C Program; Discontinues PRO 206 Pre-clinical Development
6/8/2009
More...
|